Asia Pacific Biopsy Devices Market Report by Procedure Type (Surgical Biopsy, Needle Biopsy), Product (Biopsy Guidance Systems, Needle Based Biopsy Guns, Biopsy Needles, Biopsy Forceps, and Others), Application (Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy, and Others), Guidance Technique (Ultrasound-guided Biopsy, Stereotactic-guided Biopsy, MRI-guided Biopsy, and Others), End User (Hospitals and Clinics, Academic and Research Institutes, and Others), and Country 2025-2033

Asia Pacific Biopsy Devices Market Report by Procedure Type (Surgical Biopsy, Needle Biopsy), Product (Biopsy Guidance Systems, Needle Based Biopsy Guns, Biopsy Needles, Biopsy Forceps, and Others), Application (Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy, and Others), Guidance Technique (Ultrasound-guided Biopsy, Stereotactic-guided Biopsy, MRI-guided Biopsy, and Others), End User (Hospitals and Clinics, Academic and Research Institutes, and Others), and Country 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A3556

Market Overview:

The Asia Pacific biopsy devices market size reached USD 442.4 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 867.5 Million by 2033, exhibiting a growth rate (CAGR) of 7.38% during 2025-2033.

Report Attribute 
Key Statistics
Base Year
2024
Forecast Years
2025-2033
Historical Years
2019-2024
Market Size in 2024
USD 442.4 Million
Market Forecast in 2033
USD 867.5 Million
Market Growth Rate (2025-2033) 7.38%


Biopsy devices are surgical equipment used to remove tissues from different organs. They are utilized by medical practitioners, surgeons, cardiologists, and radiologists to diagnose the presence of cancerous diseases. Some of the commonly used biopsy devices include aspiration needles, localization wires, and forceps. At present, biopsy devices are employed in medical clinics, hospitals, and diagnostic centers across the Asia Pacific region.

The increasing prevalence of cancer, along with rising initiatives for generating awareness about cancer screening programs, represents one of the significant factors driving the biopsy devices market in the Asia Pacific region. Moreover, the growing risks of infection due to improper care of invasive biopsy wounds have resulted in the introduction of stringent healthcare guidelines, which has further strengthened the market growth. Apart from this, rapid urbanization, in confluence with increasing technological advancements, is creating a positive impact on the market. However, the sudden outbreak of the coronavirus disease (COVID-19) has negatively affected the biopsy devices market as the focus of the healthcare personnel has presently shifted towards the treatment of COVID-19 patients. The market is projected to experience growth once the pandemic situation comes under control.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the Asia Pacific biopsy devices market report, along with forecasts at the regional and country levels from 2025-2033. Our report has categorized the market based on procedure type, product, application, guidance technique and end user.

Breakup by Procedure Type:

Asia Pacific Biopsy Devices Market

  • Surgical Biopsy
  • Needle Biopsy

Breakup by Product:

  • Biopsy Guidance Systems
  • Needle Based Biopsy Guns
  • Biopsy Needles
  • Biopsy Forceps
  • Others

Breakup by Application:

  • Breast Biopsy
  • Lung Biopsy
  • Colorectal Biopsy
  • Prostate Biopsy
  • Others

Breakup by Guidance Technique:

  • Ultrasound-guided Biopsy
  • Stereotactic-guided Biopsy
  • MRI-guided Biopsy
  • Others

Breakup by End User:

  • Hospitals and Clinics
  • Academic and Research Institutes
  • Others

Breakup by Country:

Asia Pacific Biopsy Devices Market by Country

  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Report Coverage:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units Million USD
Segment Coverage Procedure Type, Product, Application, Guidance Technique, End User, Country
Countries Covered China, Japan, India, South Korea, Australia, Indonesia, Others
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report

The Asia Pacific biopsy devices market was valued at USD 442.4 Million in 2024.

We expect the Asia Pacific biopsy devices market to exhibit a CAGR of 7.38% during 2025-2033.

The growing adoption of biopsy devices by radiologists, surgeons, cardiologists, and other medical practitioners to diagnose the presence or extent of diseases that are cancerous or inflammatory in nature, is primarily driving the Asia Pacific biopsy devices market.

The sudden outbreak of the COVID-19 pandemic had led to the postponement of various elective cancer treatment procedures to reduce the risk of the coronavirus infection upon hospital visits and interaction with medical equipment, thereby negatively impacting the Asia Pacific market for biopsy devices.

Based on the procedure type, the Asia Pacific biopsy devices market can be segmented into surgical biopsy and needle biopsy, where needle biopsy holds the majority of the total market share.

Based on the product, the Asia Pacific biopsy devices market has been divided into biopsy guidance systems, needle based biopsy guns, biopsy needles, biopsy forceps, and others. Among these, needle based biopsy guns currently exhibit a clear dominance in the market.

Based on the application, the Asia Pacific biopsy devices market can be categorized into breast biopsy, lung biopsy, colorectal biopsy, prostate biopsy, and others. Currently, breast biopsy accounts for the majority of the total market share.

Based on the guidance technique, the Asia Pacific biopsy devices market has been segregated into ultrasound-guided biopsy, stereotactic-guided biopsy, MRI-guided biopsy, and others. Among these, MRI-guided biopsy currently exhibits a clear dominance in the market.

Based on the end user, the Asia Pacific biopsy devices market can be bifurcated into hospitals and clinics, academic and research institutes, and others. Currently, hospitals and clinics hold the largest market share.

On a regional level, the market has been classified into China, Japan, India, South Korea, Australia, Indonesia, and others, where China currently dominates the Asia Pacific biopsy devices market.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Asia Pacific Biopsy Devices Market Report by Procedure Type (Surgical Biopsy, Needle Biopsy), Product (Biopsy Guidance Systems, Needle Based Biopsy Guns, Biopsy Needles, Biopsy Forceps, and Others), Application (Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy, and Others), Guidance Technique (Ultrasound-guided Biopsy, Stereotactic-guided Biopsy, MRI-guided Biopsy, and Others), End User (Hospitals and Clinics, Academic and Research Institutes, and Others), and Country 2025-2033
Purchase Options Discount
Offer
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials